CBAV Stock Overview
A medical company, operates a network of ophthalmology clinics. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Clínica Baviera, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €31.40 |
| 52 Week High | €39.50 |
| 52 Week Low | €22.20 |
| Beta | 0.68 |
| 1 Month Change | -10.03% |
| 3 Month Change | -11.05% |
| 1 Year Change | 37.72% |
| 3 Year Change | 52.43% |
| 5 Year Change | 145.31% |
| Change since IPO | 38.57% |
Recent News & Updates
Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
Oct 18
Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Sep 19Recent updates
Clínica Baviera (BME:CBAV) Is Achieving High Returns On Its Capital
Oct 18Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Sep 19Market Cool On Clínica Baviera, S.A.'s (BME:CBAV) Earnings
Jul 13Clínica Baviera (BME:CBAV) Might Become A Compounding Machine
Mar 01Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405
Nov 20Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital
Jan 20These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely
Sep 15Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)
Apr 12Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly
Mar 21Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 22Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return
Jan 30Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital
Jan 09
Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative
Dec 19Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet
Nov 28Shareholder Returns
| CBAV | ES Healthcare | ES Market | |
|---|---|---|---|
| 7D | -4.8% | -0.5% | -3.2% |
| 1Y | 37.7% | 5.1% | 12.1% |
Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned 5.1% over the past year.
Return vs Market: CBAV exceeded the Spanish Market which returned 12.1% over the past year.
Price Volatility
| CBAV volatility | |
|---|---|
| CBAV Average Weekly Movement | 5.1% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 3.2% |
| 10% most volatile stocks in ES Market | 6.0% |
| 10% least volatile stocks in ES Market | 0.7% |
Stable Share Price: CBAV's share price has been volatile over the past 3 months compared to the Spanish market.
Volatility Over Time: CBAV's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of Spanish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,740 | Eduardo Baviera Sabater | www.clinicabaviera.com |
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.
Clínica Baviera, S.A. Fundamentals Summary
| CBAV fundamental statistics | |
|---|---|
| Market cap | €508.37m |
| Earnings (TTM) | €37.07m |
| Revenue (TTM) | €252.47m |
13.5x
P/E Ratio2.0x
P/S RatioIs CBAV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBAV income statement (TTM) | |
|---|---|
| Revenue | €252.47m |
| Cost of Revenue | €136.51m |
| Gross Profit | €115.96m |
| Other Expenses | €78.89m |
| Earnings | €37.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.32 |
| Gross Margin | 45.93% |
| Net Profit Margin | 14.68% |
| Debt/Equity Ratio | 9.5% |
How did CBAV perform over the long term?
See historical performance and comparisonDividends
5.0%
Current Dividend Yield67%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 20:00 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clínica Baviera, S.A. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ignacio Ortiz de Mendivil | Banco BPI, S.A. |
| León Izuzquiza Lenze | Banco de Sabadell. S.A. |
| Marta Diaz | Banco de Sabadell. S.A. |